// App-Quantinova.ai

: Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

Researchers

Presenter

  • Vallari Shah

Principal Investigators

  • Amy L Sherborne

  • Sidra Ellis

  • Amy Price

  • Jack Kendall

  • Laura Chiecchio

  • Alina Striha

  • Anna Hockaday

  • Charlotte Pawlyn

  • Matthew Jenner

  • Mark T Drayson

  • Roger G Owen

  • Walter M Gregory

  • Gareth Morgan

  • Faith E. Davies

  • Richard S Houlston

  • Gordon Cook

  • David Cairns

  • Graham H Jackson

  • Martin Kaiser

Medical Centers

  • The Royal Marsden Hospital, London, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Salisbury NHS Foundation Trust, Wessex Regional Genetics Laboratory, Salisbury, United Kingdom

  • Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

  • Division of Cancer Therapeutics, Institute of Cancer Research, London, UK

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • St. James's University Hospital, Leeds, United Kingdom

  • University of Arkansas for Medical Sciences, Little Rock, AR

  • Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR

  • Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

  • Department of Haematology, Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • Thalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved